First AD

Second AD

Melanoma & Skin Cancer

The OncLive Melanoma & Skin Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of skin cancers, including melanoma, basal cell carcinoma, and more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in melanoma and other skin cancers.

Inside the Clinic: Basal Cell Carcinoma Treatment Advances

Insights

Experts review the safety and toxicity data of anti-PD-1 antibody agent cemiplimab for basal cell carcinoma treatment.

Safety of Cemiplimab for Basal Cell Carcinoma

Overview of Basal Cell Carcinoma

Clinical Scenario 1: A 74-Year-Old Man with Locally Advanced Infiltrative Basal Cell Carcinoma

Referring Patients with Basal Cell Carcinoma to Medical Oncology

Treatment Options for Locally Advanced Basal Cell Carcinoma

Systemic Therapy Options for Basal Cell Carcinoma

Monitoring Strategies for Basal Cell Carcinoma

Clinical Scenario 2: A 66-Year-Old Woman with Locally Advanced Basal Cell Carcinoma

Metastasis Patterns of Basal Cell Carcinoma

Basal Cell Carcinoma Clinical Pearls